Document Detail


Proteoglycan production by human glomerular visceral epithelial cells and mesangial cells in vitro.
MedLine Citation:
PMID:  7537959     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Proteoglycans metabolically labelled with [35S]sulphate and [3H]glucosamine or [3H]leucine were isolated from the incubation medium and cell layer of human adult mesangial cells and glomerular visceral epithelial cells using sequential DEAE chromatography purification steps followed by gel-filtration chromatography. The proteoglycan composition of each peak was analysed by treatment with HNO2, chondroitinase ABC or chondroitinase AC followed by chromatography on Sephadex G-50 columns. Heparan sulphate proteoglycan (HSPG) and dermatan sulphate proteoglycan were detected in both the culture medium and cell layer of mesangial cells. Culture medium of glomerular visceral epithelial cells contained HSPG and a second proteoglycan with the properties of a hybrid molecule containing HS and chondroitin sulphate (CS). The cell layer contained HSPG and CSPG. Detailed analysis of the hybrid molecule revealed that it had an apparent molecular mass of 400 kDa. SDS/PAGE of hybrid molecules, after treatment with heparitinase and chondroitinase ABC, revealed a core protein of 80 kDa. Using 1.8% polyacrylamide/0.6% agarose-gel electrophoresis, we deduced that the HS and CS were independently attached to one core protein. Because glomerular-basement-membrane HSPG is thought to be derived from mesangial cells and glomerular visceral epithelial cells and this molecule is involved in several kidney diseases, we investigated its synthesis in more detail. Anti-(rat glomerular-basement-membrane HSPG) monoclonal antibodies (JM403) and anti-(human glomerular-basement-membrane HSPG) polyclonal antibodies (both antibodies known to react with the large basement-membrane HSPG, perlecan) reacted strongly with HSPG obtained from both mesangial cells and glomerular visceral epithelial cells. However, the hybrid molecule did not react with these antibodies, suggesting that the HS side chain and the core protein were different from glomerular-basement-membrane HSPG. To quantify HS we performed an inhibition ELISA using mouse antibodies specific for glomerular-basement-membrane HS glycosaminoglycan side chains. Glomerular visceral epithelial cells produced significantly higher levels of HS (between 197.56 and 269.40 micrograms/72 h per 10(6) cells) than mesangial cells (between 29.8 and 45.5 micrograms/72 h per 10(6) cells) (three different cell lines; n = 3; P < 0.001). HS production by these cells was inhibited by cycloheximide, revealing that it was synthesized de novo. Expression of perlecan mRNA, demonstrated using reverse transcriptase PCR, was different in the two cell types. We conclude that glomerular visceral epithelial cells and mesangial cells have characteristic patterns of proteoglycan production. Glomerular visceral epithelial cells produced a hybrid proteoglycan containing CS and HS independently attached to its core protein.(ABSTRACT TRUNCATED AT 250 WORDS)
Authors:
N F van Det; J van den Born; J T Tamsma; N A Verhagen; L P van den Heuvel; J H Berden; J A Bruijn; M R Daha; F J van der Woude
Related Documents :
11327079 - Involvement of cyclooxygenase-2 in serum-induced prostaglandin production by human oral...
9865519 - Cyclooxygenase inhibition reveals synergistic action of vasoconstrictors on mesangial c...
17186329 - Matrix metalloproteinase-2, matrix metalloproteinase-9, and tissue inhibitor of metallo...
9076329 - Anti-mitogenic effects of sarpogrelate in cultured rat mesangial cells.
8345409 - Immune complex degradation by cultured rat mesangial cells.
7642529 - Tissue-specific enhancer-promoter interactions regulate high level constitutive express...
1707019 - Function follows form: generation of intracellular signals by cell deformation.
17663759 - From bit to it: how a complex metabolic network transforms information into living matter.
21110339 - Synthesis and in vitro anticancer activities of some selenadiazole derivatives.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Biochemical journal     Volume:  307 ( Pt 3)     ISSN:  0264-6021     ISO Abbreviation:  Biochem. J.     Publication Date:  1995 May 
Date Detail:
Created Date:  1995-06-06     Completed Date:  1995-06-06     Revised Date:  2013-01-24    
Medline Journal Info:
Nlm Unique ID:  2984726R     Medline TA:  Biochem J     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  759-68     Citation Subset:  IM    
Affiliation:
Department of Nephrology, University Hospital, Leiden, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Base Sequence
Cells, Cultured
Child
Child, Preschool
Chondroitin Sulfate Proteoglycans / analysis,  biosynthesis
Chromatography, High Pressure Liquid
DNA, Complementary / biosynthesis,  genetics
Enzyme-Linked Immunosorbent Assay
Epithelium / metabolism
Glomerular Mesangium / metabolism*
Glucosamine / metabolism
Heparan Sulfate Proteoglycans
Heparitin Sulfate / biosynthesis,  genetics
Humans
Infant
Kidney Glomerulus / cytology,  metabolism*
Leucine / metabolism
Middle Aged
Molecular Sequence Data
Polymerase Chain Reaction
Proteoglycans / biosynthesis*,  genetics
RNA / genetics,  isolation & purification,  metabolism
RNA, Messenger / analysis,  genetics
Sulfates / metabolism
Sulfur Radioisotopes
Transcription, Genetic
Tritium
Chemical
Reg. No./Substance:
0/Chondroitin Sulfate Proteoglycans; 0/DNA, Complementary; 0/Heparan Sulfate Proteoglycans; 0/Proteoglycans; 0/RNA, Messenger; 0/Sulfates; 0/Sulfur Radioisotopes; 0YPR65R21J/sodium sulfate; 10028-17-8/Tritium; 143972-95-6/perlecan; 3416-24-8/Glucosamine; 61-90-5/Leucine; 63231-63-0/RNA; 9050-30-0/Heparitin Sulfate
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Enhanced complement susceptibility of avidin-biotin-treated human erythrocytes is a consequence of n...
Next Document:  Specific binding of urinary-type plasminogen activator (u-PA) to vitronectin and its role in mediati...